MEDIA ENQUIRIES
For all media enquiries please
contact us
Celladore opens Melbourne based Australia HQ
July 2022
Celladore announces the estbalishment of APAC head office in Melbourne, Victoria. The location provides a strategic advantage to leverage the burgeoning biotech sector in Melbourne. The company expects to quickly establish itself as a recognised leader in 'go to market' commercialisation of novel and cell based therapies.
ICDS 2022
October 2022
Celladore is looking forward to attending International Society for the Study of Celiac Disease in Campania, Italy as we work towards launch of upper GI services.
Consulting and Partners
November 2022
Celladore is pleased to announce a strategic partnership agreement reached with Aeterna Health. Working together we will advance access and availability of novel therapy agents across many areas of medicine with a short term focus on osteoarthritis.
